{"schema_version":"secwatch.filing_event.v1","accession":"0000885978-23-000029","form_type":"8-K","ticker":"USPH","cik":"0000885978","company_name":"U S PHYSICAL THERAPY INC /NV","filed_at":"2023-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.879742+00:00","generated_at":"2026-06-11T23:59:57.831094+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"USPH Q2 net income $10.9M ($0.64 EPS); record patient volumes; reaffirms FY23 Adj. EBITDA guidance $75-80M","bullets":["Net income $10.9M ($0.64 GAAP EPS) vs $11.2M ($0.87) in Q2 2022; Operating Results per share $0.76 vs $0.90.","Total net revenue $151.5M (+7.7% YoY); PT operations revenue up 9.4% to $129.3M on record 30.4 visits/clinic/day.","Reaffirmed FY23 Adjusted EBITDA guidance $75-80M; Q2 Adj. EBITDA $21.7M vs $21.3M.","Board declared $0.43/share quarterly dividend payable Sept 8, record Aug 18.","Completed secondary offering of ~1.9M shares for net proceeds $163.7M, used partly to repay debt."],"urls":{"canonical":"https://secwatch.observer/filing/0000885978-23-000029","json":"https://secwatch.observer/filing/0000885978-23-000029.json","markdown":"https://secwatch.observer/filing/0000885978-23-000029.md","text":"https://secwatch.observer/filing/0000885978-23-000029.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885978/000088597823000029/0000885978-23-000029-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885978/000088597823000029/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T23:59:57.831094+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3e6af36d6b06e3ee91fabe5f04b3943a65b92f05","claim":"U S PHYSICAL THERAPY INC /NV updated its three and six months ended June 30, 2023 guidance (reaffirmed).","evidence_excerpt":"U.S. Physical Therapy Reports Second Quarter 2023 Results Reports All-Time High Quarterly Patient Volume","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/885978/000088597823000029/0000885978-23-000029-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three and six months ended June 30, 2023"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}